DSI Renal Holdings LLC - Adversary Proceeding

CourtUnited States Bankruptcy Court, D. Delaware
DecidedMarch 30, 2020
Docket14-50356
StatusUnknown

This text of DSI Renal Holdings LLC - Adversary Proceeding (DSI Renal Holdings LLC - Adversary Proceeding) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
DSI Renal Holdings LLC - Adversary Proceeding, (Del. 2020).

Opinion

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE

In re: ) Chapter 7 ) DSI RENAL HOLDINGS, LLC, et al., ) Case No. 11-11722 (KBO) ) Debtors. ) (Jointly Administered) ____________________________________ ) ) ALFRED T. GIULIANO, Chapter 7 ) Trustee, ) ) Plaintiff, ) ) v. ) Adv. Proc. No. 14-50356 (KBO) ) MICHAEL SCHNABEL, et al., ) ) Defendants. ) ____________________________________ )

OPINION1

Before the Court are the following motions for partial summary judgment filed by one or more of the Defendants in the above-captioned adversary proceeding commenced by Plaintiff Alfred T. Giuliano (the “Trustee”), as the chapter 7 trustee for the estates of DSI Renal Holdings, LLC, DSI Hospitals, Inc., and DSI Facility Development, LLC (each a “Debtor” and together the “Debtors”): (1) Defendants’ Motion For Partial Summary Judgment Excluding Proceeds Of Non- Debtor Property From Plaintiff’s Potential Recovery2 (the “Stock Motion”); (2) Motion Of Defendants Apollo Investment Corporation, Ares Capital Corporation, And Northwestern Mutual Life Insurance Company For Summary Judgment Excluding Debt Repayments From Plaintiffs’ Recovery3 (the “Debt Motion”, and together with the Stock Motion, the “Damages Motions”); and (3) The Northwestern Mutual Life Insurance Company’s Motion For Summary Judgment On Certain Of Plaintiff’s Fraudulent Transfer Claims Pursuant To 11 U.S.C. § 546(e)4 (the “Safe Harbor Motion”, and together with the Damages Motions, the “Motions”). For the reasons set forth herein, the Court will grant the Motions.

1 This Opinion constitutes the findings of fact and conclusions of law of the Court pursuant to Rule 7052 of the Federal Rules of Bankruptcy Procedure. 2 Adv. D.I. 191. 3 Adv. D.I. 184. 4 Adv. D.I. 174. I. JURISDICTION

The Court has jurisdiction over this proceeding pursuant to 28 U.S.C. §§ 1334 and 157(a). Certain Counts of the Complaint are core proceedings while others are non-core. The Trustee demands a jury trial for all Counts of the Complaint. Neither the Trustee nor the Defendants consent to the entry of a final judgment or adjudication by this Court. Nonetheless, the Court has the authority to hear and enter an order on the Motions.5

II. RELEVANT BACKGROUND6

A. The Prepetition Restructuring and Sale of the Renal Business

The claims asserted in the Trustee’s Complaint spring from a complex prepetition restructuring of Debtor DSI Renal Holdings, LLC (“DSI Renal Holdings”) and certain of its subsidiaries (the “Restructuring”). Prior to the Restructuring, non-Debtor DSI Holding Company, Inc. (“DSI Parent”) wholly owned the Debtors. DSI Parent’s indirect subsidiaries owned substantially all of the operating assets of the enterprise, including kidney dialysis clinics throughout the United States (the “Renal Business”). The Renal Business was owned by non- Debtor DSI Renal, Inc. (“DSI Renal”), a wholly owned subsidiary of Debtor DSI Renal Holdings.

On January 11, 2010, the Restructuring was effectuated through a series of transactions as contemplated by, and set forth in, a Global Restructuring Agreement (“GRA”) entered into by, among others, DSI Parent, DSI Parent’s equity holders (including Defendants The Northwestern Mutual Life Insurance Company (“NML”), Apollo Investment Corp. (“AIC”), and certain Centre Defendants7),8 DSI Renal Holdings, DSI Renal, and the lenders under DSI Renal’s credit facilities

5 See, e.g., Burtch v. Owlstone, Inc. (In re Advance Nanotech, Inc.), No. 13-51215, 2014 WL 1320145, *2 (Bankr. D. Del. Apr. 2, 2014) (“After Stern v. Marshall, the ability of bankruptcy judges to enter interlocutory orders in proceedings . . . has been reaffirmed . . . .”); Boyd v. King Par, LLC, No. 11-CV- 1106, 2011 WL 5509873, at *2 (W.D. Mich. Nov. 10, 2011) (“[U]ncertainty regarding the bankruptcy court's ability to enter a final judgment . . . does not deprive the bankruptcy court of the power to entertain all pretrial proceedings, including summary judgment motions.”). 6 The relevant background set forth in this Opinion is substantially similar to that which is detailed in the Court’s Opinion on the Defendants’ Motion For Partial Summary Judgment Limiting Any Recoveries To The Amount Necessary To Satisfy Allowed Creditor Claims issued on February 4, 2020. See Giuliano v. Schnabel (In re DSI Renal Holdings, LLC), No. 14-50356, 2020 WL 550987, at **1-3 (Bankr. D. Del. Feb. 4, 2020) (the “Capping Opinion”). 7 The Centre Defendants are Centre Partners Management LLC, Centre Bregal Partners, L.P., Centre Bregal Partners II, L.P., Centre Capital Investors IV, L.P., Centre Capital Investors V, L.P., Centre Capital Non- Qualified Investors IV, L.P., Centre Capital Non-Qualified Investors V, L.P., Centre Partners Coinvestment IV, L.P., Centre Partners Coinvestment V, L.P., Centre Partners IV, L.P., Centre Partners IV, LLC, Centre Partners V, L.P., and Centre Partners V, LLC. 8 As of the Restructuring, DSI Parent issued redeemable preferred stock, convertible preferred stock, and common stock. The redeemable preferred stock was held by NML and AIC. The convertible preferred stock and common stock was held by certain Centre Defendants, NML, and non-Defendant investors. (including certain Centre Defendants, NML, Ares Capital Corp. (“ARCC”), and AIC).9 In sum, the following relevant events occurred to effectuate the Restructuring:

 DSI Renal Holdings formed CDSI I Holding Company, Inc. (“CDSI I”), which formed a wholly owned subsidiary, CDSI II Holding Company Inc. (“CDSI II”);

 Certain Centre Defendants, AIC, NML, and ARCC converted (the “Creditors”) an aggregate of approximately $55 million of their DSI Renal subordinated debt holdings into, among other things, 55,000 DSI Renal shares (the “Debt-for-Equity Exchange”) and contributed those DSI Renal shares to CDSI I in return for, among other things, approximately 55,000 CDSI I shares;

 DSI Renal Holdings contributed all of its 1,000 DSI Renal shares (the “Renal Shares”) to CDSI I and received, among other things, one CDSI I share;

 Certain Centre Defendants and NML invested (the “Investors”) $71 million (the “New Money Investment”) into CDSI I for, among other things, approximately 77,000 CDSI I shares;

 CDSI I contributed the Investment Proceeds and 56,000 DSI Renal shares to CDSI II;

 Certain shareholders of DSI Parent received equity interests in CDSI I from the Investors and Creditors; and

 DSI Parent merged with and into DSI Renal Holdings, with DSI Renal Holdings surviving, and the former shareholders of DSI Parent receiving ownership interests in DSI Renal Holdings in the same numbers and series or classes as they held in DSI Parent prior to the Restructuring.

There is no dispute that each of the Restructuring transactions were part of an integrated transaction and that the effectiveness of each transaction was conditioned upon the substantially simultaneous consummation of the other transactions.

As a consequence of the Restructuring, DSI Renal Holdings ceased to wholly own DSI Renal. Rather, DSI Renal and its Renal Business became wholly owned by CDSI I, indirectly through its subsidiary CDSI II. DSI Renal Holdings held one share of CDSI I. Defendants Centre Defendants, NML, ARCC, and AIC, along with other non-defendants, held the remainder.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
In Re: Resorts International, Inc.
181 F.3d 505 (Third Circuit, 1999)
Pearson v. Component Technology Corporation
247 F.3d 471 (Third Circuit, 2001)
In Re Plassein Intern. Corp.
590 F.3d 252 (Third Circuit, 2009)
Bomarko, Inc. v. International Telecharge, Inc.
794 A.2d 1161 (Court of Chancery of Delaware, 1999)
Weinberger v. UOP, Inc.
457 A.2d 701 (Supreme Court of Delaware, 1983)
Thorpe by Castleman v. Cerbco, Inc.
676 A.2d 436 (Supreme Court of Delaware, 1996)
In re: Bernard L. Madoff Investment Securities LLC
773 F.3d 411 (Second Circuit, 2014)
In Re: PWS Holding Corp
303 F.3d 308 (Third Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
DSI Renal Holdings LLC - Adversary Proceeding, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dsi-renal-holdings-llc-adversary-proceeding-deb-2020.